COVID-19 and generalized Myasthenia Gravis exacerbation: A case report
- PMID: 32634699
- PMCID: PMC7316067
- DOI: 10.1016/j.clineuro.2020.106045
COVID-19 and generalized Myasthenia Gravis exacerbation: A case report
Abstract
- •
MG treatment in the context of COVID-19 should be tailored to the patient.
- •
Patient’s respiratory status should be closely monitored.
- •
Concomitant COVID-19 and MG has a variable response to treatment.
Keywords: Covid-19; Exacerbation; Myasthenia Gravis; Neuromuscular; SARS CoV2.
Figures
References
-
- Centers for Disease Control; 2020. Symptoms of Coronavirus.https://www.cdc.gov/coronavirus/2019-ncov/symptoms-testing/symptoms.html Updated March 20, 2020. Accessed May 4, 2020, website.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous
